| |
VACCR |
ICD-9 |
| |
Sensitivity |
PPV |
Sensitivity |
PPV |
| HIV+ |
124/144=86% |
124/131=95% |
131/144=91% |
131/221=59% |
| HIV- |
95/108=88% |
95/98=97% |
102/108=94% |
102/148=69% |
| Oral cavity and pharynx |
3/3=100% |
3/6=50% |
3/3=100% |
3/13=23% |
| Colorectal |
10/11=91% |
10/11=91% |
10/11=91% |
10/29=34% |
| Anal |
12/16=75% |
12/13=92% |
13/16=81% |
13/20=65% |
| Liver |
19/22=86% |
19/19=100% |
20/22=91% |
20/24=83% |
| Lung |
38/48=79% |
38/38=100% |
45/48=94% |
45/56=80% |
| Prostate |
51/56=91% |
51/52=98% |
52/56=93% |
52/62=84% |
| Non-Hodgkin lymphoma |
20/21=95% |
20/20=100% |
21/21=100% |
21/23=91% |
| Leukemia |
9/9=100% |
9/10=90% |
8/9=89% |
8/10=80% |
| Kaposi sarcoma |
10/12=83% |
10/10=100% |
12/12=100% |
12/15=80% |
| Other specified cancers†|
45/51=88% |
45/46=98% |
47/51=92% |
47/89=53% |
| Cancers of unspecified site |
2/3=67% |
2/4=50% |
2/3=67% |
2/28=7% |
*Cancer types with at least 10 VACCR or ICD-9 code diagnoses
†Cancer-type specific sensitivity and PPV for the following cancer types combined: esophagus, stomach, small intestine, biliary tract, pancreas, peritoneum and
retroperitoneum, larynx, pleura, melanoma, breast, uterus or corpus, penis, testicular, bladder, kidney, brain and nervous system, thyroid, Hodgkin lymphoma, multiple
myeloma |
